Glaucoma Treatment Market - Global Outlook and Forecast 2022-2028

January 2022 | 65 pages | ID: G69B4E6BE9BAEN
Market Monitor Global

Abstracts

Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.

This report contains market size and forecasts of Glaucoma Treatment in Global, including the following market information:

Global Glaucoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Glaucoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Prostaglandin Analogs (PGAs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glaucoma Treatment include Novartis, Allergan, Pfizer, Akorn, Teva, Bausch & Lomb, Otsuka Pharmaceutical, Santen and Lunan Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glaucoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glaucoma Treatment Market, by Product, 2017-2022, 2023-2028 ($ millions)

Global Glaucoma Treatment Market Segment Percentages, by Product, 2021 (%)

• Prostaglandin Analogs (PGAs)
• Beta Blocker
• Alpha Agonist
• Others

Global Glaucoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Glaucoma Treatment Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Pharmacy
• Other

Global Glaucoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Glaucoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glaucoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Glaucoma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Allergan
• Pfizer
• Akorn
• Teva
• Bausch & Lomb
• Otsuka Pharmaceutical
• Santen
• Lunan Pharma
• Zizhu Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glaucoma Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Product
  1.2.2 Market by Application
1.3 Global Glaucoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLAUCOMA TREATMENT OVERALL MARKET SIZE

2.1 Global Glaucoma Treatment Market Size: 2021 VS 2028
2.2 Global Glaucoma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Glaucoma Treatment Players in Global Market
3.2 Top Global Glaucoma Treatment Companies Ranked by Revenue
3.3 Global Glaucoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Glaucoma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glaucoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glaucoma Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Glaucoma Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Glaucoma Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Product - Global Glaucoma Treatment Market Size Markets, 2021 & 2028
  4.1.2 Prostaglandin Analogs (PGAs)
  4.1.3 Beta Blocker
  4.1.4 Alpha Agonist
  4.1.5 Others
4.2 By Product - Global Glaucoma Treatment Revenue & Forecasts
  4.2.1 By Product - Global Glaucoma Treatment Revenue, 2017-2022
  4.2.2 By Product - Global Glaucoma Treatment Revenue, 2023-2028
  4.2.3 By Product - Global Glaucoma Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glaucoma Treatment Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Pharmacy
  5.1.4 Other
5.2 By Application - Global Glaucoma Treatment Revenue & Forecasts
  5.2.1 By Application - Global Glaucoma Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Glaucoma Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Glaucoma Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glaucoma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Glaucoma Treatment Revenue & Forecasts
  6.2.1 By Region - Global Glaucoma Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Glaucoma Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Glaucoma Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Glaucoma Treatment Revenue, 2017-2028
  6.3.2 US Glaucoma Treatment Market Size, 2017-2028
  6.3.3 Canada Glaucoma Treatment Market Size, 2017-2028
  6.3.4 Mexico Glaucoma Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Glaucoma Treatment Revenue, 2017-2028
  6.4.2 Germany Glaucoma Treatment Market Size, 2017-2028
  6.4.3 France Glaucoma Treatment Market Size, 2017-2028
  6.4.4 U.K. Glaucoma Treatment Market Size, 2017-2028
  6.4.5 Italy Glaucoma Treatment Market Size, 2017-2028
  6.4.6 Russia Glaucoma Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Glaucoma Treatment Market Size, 2017-2028
  6.4.8 Benelux Glaucoma Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Glaucoma Treatment Revenue, 2017-2028
  6.5.2 China Glaucoma Treatment Market Size, 2017-2028
  6.5.3 Japan Glaucoma Treatment Market Size, 2017-2028
  6.5.4 South Korea Glaucoma Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Glaucoma Treatment Market Size, 2017-2028
  6.5.6 India Glaucoma Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Glaucoma Treatment Revenue, 2017-2028
  6.6.2 Brazil Glaucoma Treatment Market Size, 2017-2028
  6.6.3 Argentina Glaucoma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Glaucoma Treatment Revenue, 2017-2028
  6.7.2 Turkey Glaucoma Treatment Market Size, 2017-2028
  6.7.3 Israel Glaucoma Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Glaucoma Treatment Market Size, 2017-2028
  6.7.5 UAE Glaucoma Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Glaucoma Treatment Major Product Offerings
  7.1.4 Novartis Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Glaucoma Treatment Major Product Offerings
  7.2.4 Allergan Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Glaucoma Treatment Major Product Offerings
  7.3.4 Pfizer Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Akorn
  7.4.1 Akorn Corporate Summary
  7.4.2 Akorn Business Overview
  7.4.3 Akorn Glaucoma Treatment Major Product Offerings
  7.4.4 Akorn Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.4.5 Akorn Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Glaucoma Treatment Major Product Offerings
  7.5.4 Teva Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.5.5 Teva Key News
7.6 Bausch & Lomb
  7.6.1 Bausch & Lomb Corporate Summary
  7.6.2 Bausch & Lomb Business Overview
  7.6.3 Bausch & Lomb Glaucoma Treatment Major Product Offerings
  7.6.4 Bausch & Lomb Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.6.5 Bausch & Lomb Key News
7.7 Otsuka Pharmaceutical
  7.7.1 Otsuka Pharmaceutical Corporate Summary
  7.7.2 Otsuka Pharmaceutical Business Overview
  7.7.3 Otsuka Pharmaceutical Glaucoma Treatment Major Product Offerings
  7.7.4 Otsuka Pharmaceutical Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.7.5 Otsuka Pharmaceutical Key News
7.8 Santen
  7.8.1 Santen Corporate Summary
  7.8.2 Santen Business Overview
  7.8.3 Santen Glaucoma Treatment Major Product Offerings
  7.8.4 Santen Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.8.5 Santen Key News
7.9 Lunan Pharma
  7.9.1 Lunan Pharma Corporate Summary
  7.9.2 Lunan Pharma Business Overview
  7.9.3 Lunan Pharma Glaucoma Treatment Major Product Offerings
  7.9.4 Lunan Pharma Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.9.5 Lunan Pharma Key News
7.10 Zizhu Pharma
  7.10.1 Zizhu Pharma Corporate Summary
  7.10.2 Zizhu Pharma Business Overview
  7.10.3 Zizhu Pharma Glaucoma Treatment Major Product Offerings
  7.10.4 Zizhu Pharma Glaucoma Treatment Revenue in Global Market (2017-2022)
  7.10.5 Zizhu Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Glaucoma Treatment Market Opportunities & Trends in Global Market
Table 2. Glaucoma Treatment Market Drivers in Global Market
Table 3. Glaucoma Treatment Market Restraints in Global Market
Table 4. Key Players of Glaucoma Treatment in Global Market
Table 5. Top Glaucoma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glaucoma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glaucoma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glaucoma Treatment Product Type
Table 9. List of Global Tier 1 Glaucoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glaucoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Product – Global Glaucoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Product - Glaucoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Product - Glaucoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Glaucoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glaucoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glaucoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Glaucoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glaucoma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glaucoma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glaucoma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glaucoma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glaucoma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glaucoma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glaucoma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glaucoma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glaucoma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glaucoma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glaucoma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glaucoma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Glaucoma Treatment Product Offerings
Table 32. Novartis Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Glaucoma Treatment Product Offerings
Table 35. Allergan Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Glaucoma Treatment Product Offerings
Table 38. Pfizer Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Akorn Corporate Summary
Table 40. Akorn Glaucoma Treatment Product Offerings
Table 41. Akorn Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Glaucoma Treatment Product Offerings
Table 44. Teva Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bausch & Lomb Corporate Summary
Table 46. Bausch & Lomb Glaucoma Treatment Product Offerings
Table 47. Bausch & Lomb Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Otsuka Pharmaceutical Corporate Summary
Table 49. Otsuka Pharmaceutical Glaucoma Treatment Product Offerings
Table 50. Otsuka Pharmaceutical Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Santen Corporate Summary
Table 52. Santen Glaucoma Treatment Product Offerings
Table 53. Santen Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Lunan Pharma Corporate Summary
Table 55. Lunan Pharma Glaucoma Treatment Product Offerings
Table 56. Lunan Pharma Glaucoma Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Zizhu Pharma Corporate Summary
Table 58. Zizhu Pharma Glaucoma Treatment Product Offerings
Table 59. Zizhu Pharma Glaucoma Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Glaucoma Treatment Segment by Product in 2021
Figure 2. Glaucoma Treatment Segment by Application in 2021
Figure 3. Global Glaucoma Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Glaucoma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glaucoma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glaucoma Treatment Revenue in 2021
Figure 8. By Product - Global Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 12. US Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 24. China Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glaucoma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glaucoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Akorn Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch & Lomb Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Otsuka Pharmaceutical Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Santen Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lunan Pharma Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zizhu Pharma Glaucoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)